The largest database of trusted experimental protocols

Brachyvision treatment planning system

Manufactured by Agilent Technologies
Sourced in United States

BrachyVision is a treatment planning system developed by Agilent Technologies for brachytherapy procedures. It provides functionality for treatment planning and simulation to support medical professionals in their delivery of brachytherapy treatments.

Automatically generated - may contain errors

2 protocols using brachyvision treatment planning system

1

HDR Brachytherapy for Breast Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
High-dose-rate brachytherapy was done using 192Ir source of 370 GBq initial activity with GammaMed HDR Plus afterloading machine (Varian Medical Systems, Inc., Palo Alto, CA, USA). Target definition and delineation was done according GEC-ESTRO Breast Cancer Working Group recommendations [26 (link)]. Post implantation CT images were transferred to BrachyVision treatment planning system (Varian Medical Systems, Inc., Palo Alto, CA, USA), on which the target volume segmentation and planning was performed. After the tumor bed was identified, a margin of 1.5 cm was uniformly expanded while keeping a minimum distance of 5 mm from the skin surface to create a CTV. Posteriorly, the CTV did not expand to the chest wall muscles. Planning target volume (PTV) was the same as CTV. After catheters’ reconstruction, a geometrical optimization with subsequent manual modification of the dwell times and positions was done to achieve homogenous dose distribution among the CTV. The aimed dose constraints for the plan were: V100 for CTV > 90%, dose non-homogeneity ratio (DNR, relation of volume received 150% of prescribed dose to the volume received 100% of prescribed dose, V150/V100%) was ≤ 0,33, and the dose to the skin surface and chest wall ≤ 70% of prescribed dose. Twenty two patients received 8 times 4 Gy, and twenty six patients 7 times 5 Gy fractions.
+ Open protocol
+ Expand
2

Validation of CivaDot™ Brachytherapy Source

Check if the same lab product or an alternative is used in the 5 most similar protocols
Source information for the CivaDot™ was entered in the BrachyVision treatment planning system (TPS) (Varian Medical Systems, Inc. of Palo Alto, CA). Source geometry was entered from published parameters (14 (link)), with rounding and interpolation necessary to fit the BrachyVision templates. Test plans were generated for a single source and for a 6 × 6 array for sources. Doses calculated by BrachyVision to a set of representative points were compared to an independent implementation of the TG-43 2D formalism written in MATLAB (MathWorks, Inc, Natick, MA), using the same source specifications and dosimetry tables provided in Rivard et al. (14 (link)) without any modification. Feasibility of CivaSheet™ post-implant reconstruction was evaluated.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!